- Home
- DIBS vs FBRX Comparison
DIBS vs FBRX Comparison
Compare DIBS & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- FBRX
- Stock Information
- Founded
- DIBS 2000
- FBRX N/A
- Country
- DIBS United States
- FBRX United States
- Employees
- DIBS 237
- FBRX N/A
- Industry
- DIBS Catalog/Specialty Distribution
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- DIBS Consumer Discretionary
- FBRX Health Care
- Exchange
- DIBS Nasdaq
- FBRX Nasdaq
- Market Cap
- DIBS 132.5M
- FBRX 125.9M
- IPO Year
- DIBS 2021
- FBRX N/A
- Fundamental
- Price
- DIBS $3.63
- FBRX $14.70
- Analyst Decision
- DIBS Buy
- FBRX Strong Buy
- Analyst Count
- DIBS 2
- FBRX 4
- Target Price
- DIBS $8.00
- FBRX $77.58
- AVG Volume (30 Days)
- DIBS 100.2K
- FBRX 61.1K
- Earning Date
- DIBS 02-26-2025
- FBRX 11-14-2024
- Dividend Yield
- DIBS N/A
- FBRX N/A
- EPS Growth
- DIBS N/A
- FBRX N/A
- EPS
- DIBS N/A
- FBRX N/A
- Revenue
- DIBS $86,409,000.00
- FBRX N/A
- Revenue This Year
- DIBS $5.17
- FBRX N/A
- Revenue Next Year
- DIBS $7.90
- FBRX N/A
- P/E Ratio
- DIBS N/A
- FBRX N/A
- Revenue Growth
- DIBS N/A
- FBRX N/A
- 52 Week Low
- DIBS $3.37
- FBRX $4.11
- 52 Week High
- DIBS $6.30
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- DIBS 48.31
- FBRX 39.02
- Support Level
- DIBS $3.56
- FBRX $13.82
- Resistance Level
- DIBS $3.70
- FBRX $17.81
- Average True Range (ATR)
- DIBS 0.11
- FBRX 2.76
- MACD
- DIBS 0.02
- FBRX -0.98
- Stochastic Oscillator
- DIBS 74.19
- FBRX 7.24
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company's single reportable and operating segment contains two reporting units; 1stDibs, which consists of the company's online marketplace that enables commerce between sellers and buyers; and Design Manager, which is the company's separate online platform that is used to sell a software solution to interior designers. It generates revenue primarily from fees from seller marketplace services as well as other services, including advertisements and software services.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).